The mechanism of SGLT2 inhibition in glucose control

3' education - July 24, 2015

A mechanism of action animation of SGLT2-inhibition, a diabetes therapy that directly targets glucose by reducing renal glucose reabsorption, independently of beta cell function and insulin resistance.

Provided as an educational service by Boehringer Ingelheim - Lilly

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.